Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
Gene Biotherapeutics, Inc. (CRXM) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/18/2021 SC 13D/A Jemapete Christopher J reports a 27.6% stake in GENE BIOTHERAPEUTICS, INC.
09/19/2012 SC 13D/A SABBY MANAGEMENT, LLC reports a 8.5% stake in CARDIUM THERAPEUTICS, INC.
12/08/2005 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
11/15/2005 SC 13D/A ZUCKER MARK S reports a 7.3% stake in ARIES VENTURES INC.
11/10/2005 SC 13D/A WEINGARTEN ROBERT N has filed a Schedule 13D for ARIES VENTURES INC.
05/21/2004 SC 13D/A MILAN DIVO reports a 11.7% stake in ARIES VENTURES INC.
12/05/2003 SC 13D/A ZUCKER MARK S reports a 64.8% stake in ARIES VENTURES INC.
09/25/2002 SC 13D/A Cardium Therapeutics, Inc. reports a 43.2% stake in ARIES VENTURES INC.
05/09/2000 SC 13D/A ELLIOTT ASSOCIATES, L.P. reports a 31.2% stake in Aries Ventures Inc.
05/02/2000 SC 13D/A ZUCKER MARK S reports a 39.5% stake in CASMYN CORP.
02/24/1999 SC 13D/A GLOBAL CAPITAL MANAGEMENT INC reports a 5.6% stake in Casmyn Corp.
01/15/1999 SC 13D/A ZUCKER MARK S reports a 15.6% stake in Casmyn Corp.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy